Faculty
Dr. Luis Pinillos Ashton
Doctor in Medicine- Cayetano Heredia University
Radiation Oncologist- Oncosalud AUNA
Fellow of the Royal College of Radiology England FRCR
Emeritus Professor- Universidad Cayetano Heredia
Honorary Professor- Universidad Ricardo Palma
Founding President Oncosalud
Founding President ALATRO( Latín american radiotherapy society)
Former Peruvian Minister of Health
Former Director of INEN (National Cancer Institute)
Former President of CLACTA (Latín American Coalition for Tobacco Control)
Former member Medical Committee ICRP
Former Peruvian representative to UNSCEAR
Founding President of COLAT. (anti tobacco national coalition)
Academician of the Peruvian National Academy of Medicine
Javier Cortés, MD PhD
• International Breast Cancer Center (IBCC), Barcelona, Spain
• Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain
• Medica Scentia Innovation Research (MedSIR), Barcelona, Spain & New Jersey, US
Dr. Javier Cortes received a degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1996, specialist in Medical Oncology by the Clínica Universitaria de Navarra, and awarded the title of Doctor in Medical Oncology from the University of Navarra in 2002. From June 2003 to July 2015, he has worked in the Department of Medical Oncology at the Hospital Vall d’Hebron, Barcelona, where he has been Coordinator of the Teaching and Training Programme for Residents in Oncology. In addition he was the Head of the Breast Cancer Program from July 2006 to August 2015. From September 2015 to October 2018, he has been Head of the Breast Cancer and Gynecological tumors at Ramon y Cajal University Hospital in Madrid. Dr. Cortes was the Head of the Breast Cancer Program at IOB Institute of Oncology, Quironsalud group, in both Madrid and Barcelona, from 2011 to September 2020. He has been Senior Clinical Investigator of the Breast Cancer Research Program at Vall d’Hebron Institute of Oncology from 2011 to February 2022.
Dr. Cortés is the Head of the International Breast Cancer Centre (IBCC) in Barcelona, founding partner of Medica Scientia innovation Research (MedSIR), a company involved in the clinical development of clinical trials.
In addition to his medical specialties, he has two master degrees in “Medical Direction and Clinical Management” by the Universidad Nacional de Educación a Distancia (UNED) and “Research methodology in Health Sciences” by the Universidad Autonoma de Barcelona and a degree in “Statistics in Health Sciences” by the Universidad Autonoma de Barcelona.
He has contributed to over 430 peer-reviewed publications, especially about breast tumours and new drugs and more than 800 communications at different conferences. He actively participates in the development of numerous international clinical trials, and he is an ad hoc reviewer of various oncology journals, including, New England Journal of Medicine, Lancet, Lancet Oncology, Annals of Oncology or Journal of Clinical Oncology, among many others
Dr Cortés is an active member of the Spanish, European, and American Societies of Medical Oncology (SEOM, ESMO, ASCO). In addition, he is a member of the Scientific Committee of the European Society for Medical Oncology (ESMO), of the Scientific Committee of the European Breast Cancer Conference (EBCC), has been chair for breast cancer at the ESMO 2020 congress, and co-chair of the same section in the congress of the American Association for Cancer Research (AACR) 2020, as well as the immunotherapy area of the AACR 2021 congress. He is a member of the expert panel that develops the treatment guidelines for metastatic breast cancer of the European Society for Medical Oncology, member of the ABC Conference, member of the ASCO International Affairs Committee, member of the executive panel in charge of SABCS Strategic Planning, and co-organizer of the Annual Congress of Controversies in Breast Cancer (CoBrCa).
In addition, according to the American Expertscape 2023 ranking, he is considered the world’s leading expert on HER2+ and fourth world oncologist with the greatest expertise in breast cancer and in 2022 and 2023 was identified as Clarivate™ world’s most influential researchers.
Dr. Richard De Boer completed his basic medical and oncology training at the Royal Melbourne Hospital and then in 1997 undertook a 3-year breast and lung cancer clinical research fellowship at the Royal Marsden Hospital in London, working with Professor Ian Smith.
He returned to Melbourne in 2000 and since then has been a consultant medical oncologist working in both public and private practice. His primary areas of clinical interest are in breast and lung cancer, with breast cancer interests focusing on endocrine therapy and mechanisms of resistance, treatment-induced bone loss and bone metastases, and biological predictors of response/survival. He is actively involved in clinical research, and is a member of the Australian New Zealand Breast Cancer Trials Group, and head of the Breast Trials group of Cancer Trials Australia. He has authored or co-authored articles appearing in journals such as the Journal of Clinical Oncology, Annals of Oncology, The Breast and British Journal of Cancer.
Antonio Llombart Cussac MD, PhD
Medical doctor and specialist in medical oncology. He is currently head of the Medical Oncology Service at the Arnau de Vilanova Hospital in Valencia and full professor of Clinical Oncology at the Catholic University of Valencia.
With more than 5 years of academic and research training in France and the United States, he is an international expert in breast cancer, with more than 100 indexed publications in the last 5 years. Involved in different Breast Cancer research groups, he is a founding partner and senior-expert at MedSIR (2012), a company dedicated to promoting high-impact clinical research in collaboration with the scientific community, pharmaceutical and biotech companies.
He has been secretary of the Spanish Society of Medical Oncology (1998-2002 and 2012-2016), scientific coordinator (2006-2010) and past-president (2010-2014) of the SOLTI Research Group. He is a member of different scientific societies (SEOM, ESMO, ASCO, AACR, ECO). Since 2017 he has been a reference academician of the Royal Academy of Medicine and Sciences of the Valencian Community.
Prof. Bruce Mann is Professor of Surgery at the University of Melbourne and Director of The Breast Service at the Royal Melbourne and Royal Women’s Hospital in Melbourne. He is on the council of Breast SurgANZ, the Scientific Advisory Committee of the ANZ Breast Cancer Trials Group and is past president of the Clinical Oncology Society of Australia. He has been involved in many clinical trials and much clinical and translational research regarding breast cancer, with his main research interest being tailoring treatment to the disease and the patient.
Stuart McIntosh is Professor of Surgical Oncology at Queen’s University in Belfast, and a consultant oncoplastic breast surgeon at Belfast City Hospital.
Stuart is an experienced clinical trialist, with a particular interest in neoadjuvant, peri-surgical and treatment de-escalation studies, and is Chief Investigator for the UK SMALL trial, as well as holding surgical leadership roles in several other trials. He is also one of the Royal College of Surgeons Surgical Specialty Leads for Breast Surgery, responsible for supporting the development and delivery of breast cancer surgical trials nationally. Additionally, he chairs the Northern Ireland Cancer Trials Network, responsible for the delivery of cancer trials across the five cancer hospitals in Northern Ireland. Stuart’s laboratory research interests include the DNA damage driven immune response in breast cancer.
Dr. Henry Gomez Moreno
Medical Oncologist- Clinica Oncosalud AUNA
Associate Research Professor- Research Institute of Biomedical Sciences- Universidad Ricardo Palma
Profesor- Universidad Cayetano Heredia
Scientific Advisor- AUNA Ideas
Member of the Latin American Cooperative Oncology Group (LACOG)
Principal Investigator for the International Breast Cancer Study Group (IBCSG), the Breast Cancer Group (BIG) and the Eastern Cooperative Oncology Group (ECOG)
Member of the National Academy of Medicine of Peru
Distinguished Researcher by the National Council of Science, Technology and Technological Innovation (Concytec)
Nirmala Pathmanathan, Australia
Nirmala Pathmanathan
Nirmala Pathmanathan is a specialist breast pathologist. She is the Director of the Westmead Breast Cancer Institute in Sydney (a multidisciplinary breast diagnostic and treatment centre servicing Western Sydney), a specialist breast pathologist with Douglass Hanly Moir Pathology in Sydney and the Director for BreastScreen Program for Sydney West. She is a Clinical Associate Professor with the University of Sydney, Faculty of Medicine and Health.
Shelley Potter PhD FHEA FRCS
Shelley Potter is Professor of Surgical Oncology at Bristol Medical School and Consultant Oncoplastic Breast Surgeon at North Bristol NHS Trust.
Her research interests focus on improving outcomes for women with breast cancer through the development and delivery of high-quality patient-centred research. She is an experienced researcher who had led several national and international collaborative oncoplastic and reconstructive breast surgical projects including the iBRA and TEAM studies and is currently Chief Investigator for Brighter, ANTHEM and Pre-BRA. Recent work has focused on optimisation of breast cancer treatment.
Her leadership national roles include Royal College of Surgeons of England Surgical Specialty Lead for Breast Surgery, Chair of iBRA-NET and Secretary to the British Breast Group.
Dr. Mauricio León Rivera
Oncologist – Mastologist
Chief of Breast Oncology Surgery – Clinica Ricardo Palma
President- Peruvian Society of Surgical Oncology
Director- Liga Contra el Cancer
Member of the Peruvian Academy of Surgery
Associate Member of the Peruvian Society of Mastology
Member of the Peruvian Society of Cancerology
Member of the European Society of Medical Oncologists
Member of the American Society of Oncology
Member of the American Society of Breast Surgeons
Editorial Director Magazine International HIR-Peruvian Edition
Founder and President of the MAUCHIS Association against Cancer.
Author of the “ATLAS OF PERUVIAN MASTOLOGY” 1st and 2nd Edition